Who we are
We are a world-leading consumer health company with a clear purpose to deliver better everyday health with humanity.
Our leading brands are built on science, innovation and human understanding and are trusted by millions of consumers globally. Haleon has a strong portfolio of brands and is well positioned to play a vital role for people all around the world, in a sector that is growing and more relevant than ever.
The definition of consumer healthcare varies across competitors and industry data sources. We define it as consisting of Oral Health, VMS and Over-the-Counter (OTC). Within OTC, Haleon's portfolio comprises of Pain, Respiratory, Digestive and Other.
Market1
Global categories1
Power Brands
Revenue
Our deep human understanding, combined with our trusted science, is our competitive advantage.
We invest in a suite of proprietary assets to build deep human understanding - to generate consumer insights, create fit for purpose innovation and communication, and enhance our engagement with health professionals who help educate consumers. These include dedicated shopper research centres, and consumer understanding and social listening data. There is a huge opportunity to improve people’s quality of life, not just treat their health needs. That is why deep human understanding will always be our starting point.
We leverage the technical and scientific expertise that comes from our scientists, supported by strong regulatory understanding and underpinned by scientific evidence generation to support new differentiating claims. During the year, we delivered 94 publications supporting our expert engagement and product claims. We continue to invest in research and development (R&D) to support our innovation.
Innovation plays an important role in delivering our purpose. Through innovation, we find new and better ways to address what people truly need on their health journeys. Leveraging consumer understanding and trusted science, we develop everyday health solutions for underserved and unmet needs, address emerging trends and improve delivery mechanisms for existing products. Our focus on innovation also helps us advance our responsible business agenda, through trusted ingredients, sustainable packaging improvements and inclusive design.
To build our brands, we invest in advertising and promotion (A&P) activities, such as paid media, omnichannel brand activations and in-store and online consumer experiences. We also have a strong focus on building data, analytics and digital capabilities. With these investments, we aim to enhance our equity in brands that consumers trust, thereby empowering more people to self care.
We partner with Health Professionals far beyond our brands, working towards a shared ambition to deliver better everyday health for all. We have direct and trusted relationships with more than 3.5m Health Professionals, and partner with a large network of pharmacies. They recognise the strength and efficacy of our products, which they trust and recommend to consumers, bringing new users to our brands and categories.
Our competitive strengths combined with our ability to innovate, build brands and drive expert advocacy creates a sustainable model for growth, and deliver attractive returns.
1 Over the medium term, the Company expects annual organic revenue growth of 4–6%.
2 Definitions and calculations of non-IFRS measures can be found from page 43 in the Annual Report 2024.
3 Includes purchase of Property, Plant and Equipment (PP&E) and intangible assets.
Related
